Active, not recruiting
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
NCT05063916
- Conditions
- Carcinoma, Carcinomas, Cervical Cancer, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States